Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT

Author(s):
Cremers, E.M.P.; Biezen, A. van; Wreede, L.C. de (0000-0002-7667-9369); Scholten, M.; Vitek, A.; Finke, J.; Platzbecker, U.; Beelen, D.; Schwerdtfeger, R.; Volin, L.; Harhalakis, N.; Blijlevens, N.; Nagler, A.; Kroger, N.; Witte, T. de
Published
2016
Publication type
Article / Letter to editor
Myelodysplastic syndromesRed blood cell transfusionIron overloadAllogeneic hematopoietic stem cell transplantationComorbidityAllogeneic stem cell transplantationPrognosis
Date issued
2016-12-31
Language
English
Is part of
Annals of Hematology (2016), Vol. 95, no. 12, p. 1971-1978
hdl
1887/112878
doi
10.1007/s00277-016-2802-z